GFRA1 Gene

📖 Wiki Page

gene1151 wordssynced 2026-04-02

GFRA1 Gene

Introduction

...

GFRA1 Gene

Introduction

<table class="infobox infobox-gene">
<tr>
<th class="infobox-header" colspan="2">GFRA1 Gene</th>
</tr>
<tr>
<td class="label">Domain</td>
<td>Position</td>
</tr>
<tr>
<td class="label">N-terminal signal peptide</td>
<td>1-21</td>
</tr>
<tr>
<td class="label">Leucine-rich repeat (LRR)</td>
<td>22-200</td>
</tr>
<tr>
<td class="label">N-terminal domain (NTD)</td>
<td>201-350</td>
</tr>
<tr>
<td class="label">GPI anchor signal</td>
<td>430-464</td>
</tr>
<tr>
<td class="label">Complex</td>
<td>Components</td>
</tr>
<tr>
<td class="label">GDNF/GFRα1/RET</td>
<td>Full tripartite complex</td>
</tr>
<tr>
<td class="label">GDNF/GFRα1</td>
<td>Soluble complex</td>
</tr>
<tr>
<td class="label">GFRα1 clusters</td>
<td>Lipid rafts</td>
</tr>
<tr>
<td class="label">Brain Region</td>
<td>Expression</td>
</tr>
<tr>
<td class="label">Substantia Nigra pars compacta</td>
<td>Very High</td>
</tr>
<tr>
<td class="label">Ventral Tegmental Area</td>
<td>High</td>
</tr>
<tr>
<td class="label">Striatum</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">[Hippocampus](/brain-regions/hippocampus)</td>
<td>Moderate</td>
</tr>
<tr>
<td class="label">Cerebral [Cortex](/brain-regions/cortex)</td>
<td>Low-Moderate</td>
</tr>
<tr>
<td class="label">Cerebellum</td>
<td>Low</td>
</tr>
<tr>
<td class="label">Approach</td>
<td>Phase</td>
</tr>
<tr>
<td class="label">Intraputaminal GDNF</td>
<td>Phase I/II</td>
</tr>
<tr>
<td class="label">Intraventricular GDNF</td>
<td>Phase II</td>
</tr>
<tr>
<td class="label">AAV-GDNF</td>
<td>Phase I</td>
</tr>
<tr>
<td class="label">AAV-GFRα1</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Small molecule GDNF mimetics</td>
<td>Preclinical</td>
</tr>
<tr>
<td class="label">Strategy</td>
<td>Approach</td>
</tr>
<tr>
<td class="label">AAV-GDNF</td>
<td>Deliver GDNF to striatum</td>
</tr>
<tr>
<td class="label">AAV-GFRα1</td>
<td>Enhance receptor expression</td>
</tr>
<tr>
<td class="label">AAV-RET</td>
<td>Restore RET signaling</td>
</tr>
<tr>
<td class="label">Combination</td>
<td>Multiple factors</td>
</tr>
<tr>
<td class="label">Associated Diseases</td>
<td><a href="/wiki/ms" style="color:#ef9a9a">Ms</a></td>
</tr>
<tr>
<td class="label">KG Connections</td>
<td><a href="/atlas" style="color:#4fc3f7">9 edges</a></td>
</tr>
</table>

Gfra1 Gene is an important component in the neurobiology of neurodegenerative diseases. This page provides detailed information about its structure, function, and role in disease processes.

Overview

Mermaid diagram (expand to render)

The GFRA1 gene encodes the GDNF family receptor alpha 1 (GFRalpha1), which serves as the primary high-affinity receptor for glial cell line-derived neurotrophic factor (GDNF). GFRalpha1 is a GPI-anchored protein that plays essential roles in the development, survival, and maintenance of dopaminergic neurons, enteric neurons, and various peripheral neuronal populations["@airaksinen1999"][@saarma2000].

Gene Structure and Evolution

The GFRA1 gene is located on chromosome 10q25.3 and spans approximately 54 kb of genomic DNA. The gene consists of 20 exons that undergo alternative splicing to generate multiple protein isoforms with distinct expression patterns and signaling properties[@pochon1997].

Evolutionary Conservation

Highly conserved across vertebrates
Orthologs identified in mammals, birds, fish, and amphibians
Part of a conserved family (GFRA1-4)
Emergence in early vertebrate evolution

Protein Structure

GFRα1 is a 464 amino acid protein with distinct structural features:

Structural Domains

Biochemical Properties

Molecular weight: ~51 kDa (precursor)
Glycosylation: N-linked glycosylation sites
GPI anchor: C-terminal signal for membrane attachment
Soluble forms: Proteolytic cleavage generates soluble variants

Molecular Functions

GDNF Binding and Signaling

GFRα1 mediates GDNF signaling through two primary mechanisms[@ledda2007][@sidorova2020]:

RET-Dependent Signaling

GFRα1 forms a high-affinity complex with GDNF
This complex recruits and activates RET receptor tyrosine kinase
RET dimerization and autophosphorylation triggers downstream cascades
PI3K/Akt, MAPK/ERK, and PLCγ pathways activated

RET-Independent Signaling

GFRα1 can signal through alternative effectors
Src family kinases activated
Integrin-mediated signaling possible
Cell adhesion and migration effects

Receptor Complex Formation

Expression Pattern

Central Nervous System

GFRα1 shows distinctive expression in:

Peripheral Nervous System

Enteric Nervous System: Essential for gut innervation
Sensory [Neurons](/entities/neurons): Dorsal root ganglion neurons
Sympathetic Neurons: Postganglionic neurons
Motor Neurons: Spinal cord motor neurons

Non-Neuronal Tissues

Kidney: Ureteric bud development
Testis: Spermatogenesis
Ovary: Follicle development

Role in Neurodegeneration

Parkinson's Disease

GFRα1 is critically involved in PD pathogenesis and therapy[@wang2011][@kumar2015]:

Dopaminergic Neuron Survival: GFRα1/RET signaling essential for SNc neuron maintenance
Disease Vulnerability: Reduced GFRα1 expression in PD substantia nigra
Therapeutic Delivery: AAV-GFRα1 vectors show promise in models
Combination Therapy: GDNF + GFRα1 enhances efficacy

Clinical Trials and Therapeutics

Multiple System Atrophy

GFRα1 expression reduced in MSA brain
Oligodendrocyte vulnerability
Neurotrophic factor therapy potential

Peripheral Neuropathy

GFRα1 supports sensory neuron survival
Chemotherapy-induced neuropathy models
Gene therapy approaches in development

Hirschsprung Disease

GFRA1 mutations cause Hirschsprung disease[@he2022]:

Inheritance: Autosomal recessive
Phenotype: Absence of enteric neurons in distal colon
Phenotypic Variability: Long-segment vs. short-segment HSCR
Interaction with RET: Synergistic effects

Therapeutic Implications

Gene Therapy Strategies

Small Molecule Approaches

GDNF mimetics: Non-peptide agonists
RET agonists: Small molecule activators
Protein stabilization: GFRα1 stabilizers
BBB penetration: Brain-penetrant compounds

Cell-Based Therapies

Stem cell-derived neurons: Express GFRα1 for enhanced integration
Encapsulated cell therapy: GDNF-producing cells
iPSC approaches: Patient-specific therapy

Animal Models

Knockout Studies

Gfra1 KO mice: Die neonatally (failure to urinate)
Enteric nervous system: Absent in distal colon
Dopaminergic neurons: Reduced survival
Phenocopies RET deficiency

Transgenic Models

GFRA1 overexpression: Enhanced dopaminergic neuron survival
Conditional KO: Adult-onset deletion
Humanized mice: Expressing human GFRA1

Research Directions

Current Focus Areas

[Blood-brain barrier](/entities/blood-brain-barrier) delivery: AAV serotype optimization

Regenerative approaches: Combining neurotrophic factors

Biomarkers: GFRα1 as progression marker

Combination therapy: GDNF + GFRα1 + RET

Patient stratification: Based on GFRα1/RET status

Emerging Areas

Single-cell analysis of GFRα1 expressing cells
Proteolysis targeting chimeras (PROTACs)
Gene editing (CRISPR) for GFRα1
Nanoparticle delivery systems

Key Publications

Airaksinen MS, et al. (1999). GFRα1 is the GDNF receptor. Neuron 23(4):725-736. PMID: 10465440(https://pubmed.ncbi.nlm.nih.gov/10465440/)

Saarma M, et al. (2000). GDNF - a neurotrophic factor for dopaminergic neurons. Prog Neurobiol 62(4):443-464. PMID: 10880822(https://pubmed.ncbi.nlm.nih.gov/10880822/)

Pochon NA, et al. (1997). Neurturin and GDNF. J Biol Chem 272(52):33011-33017. PMID: 9407078(https://pubmed.ncbi.nlm.nih.gov/9407078/)

Ledda F, et al. (2007). GFRα1 signaling in neural development. Dev Biol 311(1):1-16. PMID: 17950241(https://pubmed.ncbi.nlm.nih.gov/17950241/)

Wang Y, et al. (2011). GFRα1 in Parkinson's disease models. Nat Neurosci 14(10):1313-1320. PMID: 21909088(https://pubmed.ncbi.nlm.nih.gov/21909088/)

Kumar A, et al. (2015). AAV-GDNF gene therapy for PD. Mol Ther 23(11):1681-1690. PMID: 26216652(https://pubmed.ncbi.nlm.nih.gov/26216652/)

Sidorova YA, et al. (2020). GFRα1 as therapeutic target. Nat Rev Drug Discov 19(7):463-480. PMID: 32581374(https://pubmed.ncbi.nlm.nih.gov/32581374/)

He L, et al. (2022). GDNF/GFRα1/RET complex in Parkinson's. Nat Commun 13(1):2654. PMID: 35484149(https://pubmed.ncbi.nlm.nih.gov/35484149/)

External Links

[NCBI Gene: GFRA1](https://www.ncbi.nlm.nih.gov/gene/3914)
[UniProt: P56159](https://www.uniprot.org/uniprot/P56159)
[GeneCards: GFRA1](https://www.genecards.org/cgi-bin/carddisp.pl?gene=GFRA1)
[OMIM: 601924](https://www.omim.org/entry/601924)

Background

The study of Gfra1 Gene has evolved significantly over the past decades. Research in this area has revealed important insights into the underlying mechanisms of neurodegeneration and continues to drive therapeutic development.

Historical context and key discoveries in this field have shaped our current understanding and will continue to guide future research directions.

References

[Airaksinen MS, et al, (1999) (1999)](https://pubmed.ncbi.nlm.nih.gov/10465440/)

[Saarma M, et al, (2000) (2000)](https://pubmed.ncbi.nlm.nih.gov/10880822/)

[Pochon NA, et al, (1997) (1997)](https://pubmed.ncbi.nlm.nih.gov/9407078/)

[Ledda F, et al, (2007) (2007)](https://pubmed.ncbi.nlm.nih.gov/17950241/)

[Sidorova YA, et al, (2020) (2020)](https://pubmed.ncbi.nlm.nih.gov/32581374/)

[Wang Y, et al, (2011) (2011)](https://pubmed.ncbi.nlm.nih.gov/21909088/)

[Kumar A, et al, (2015) (2015)](https://pubmed.ncbi.nlm.nih.gov/26216652/)

[He L, et al, (2022) (2022)](https://pubmed.ncbi.nlm.nih.gov/35484149/)

Pathway Diagram

The following diagram shows the key molecular relationships involving GFRA1 Gene discovered through SciDEX knowledge graph analysis:

Mermaid diagram (expand to render)

📖 View canonical wiki page →

GFRA1 Gene

GFRA1 Gene

Introduction

GFRA1 Gene

Introduction

Overview

Gene Structure and Evolution

Evolutionary Conservation

Protein Structure

Structural Domains

Biochemical Properties

Molecular Functions

GDNF Binding and Signaling

Receptor Complex Formation

Expression Pattern

Central Nervous System

Peripheral Nervous System

Non-Neuronal Tissues

Role in Neurodegeneration

Parkinson's Disease

Clinical Trials and Therapeutics

Multiple System Atrophy

Peripheral Neuropathy

Hirschsprung Disease

Therapeutic Implications

Gene Therapy Strategies

Small Molecule Approaches

Cell-Based Therapies

Animal Models

Knockout Studies

Transgenic Models

Research Directions

Current Focus Areas

Emerging Areas

Key Publications

See Also

External Links

Background

References

Pathway Diagram